• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Insurance coverage and patient outcomes: Understanding changes in esophageal cancer treatment.保险覆盖范围与患者治疗结果:了解食管癌治疗的变化
World J Gastrointest Oncol. 2025 Jul 15;17(7):107154. doi: 10.4251/wjgo.v17.i7.107154.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Beyond numbers: Public health insurance and oesophageal cancer mortality risk.超越数字:公共医疗保险与食管癌死亡风险
World J Gastrointest Oncol. 2025 Jul 15;17(7):107460. doi: 10.4251/wjgo.v17.i7.107460.
5
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
6
Are Detailed, Patient-level Social Determinant of Health Factors Associated With Physical Function and Mental Health at Presentation Among New Patients With Orthopaedic Conditions?详细的患者层面的健康社会决定因素是否与新骨科患者就诊时的身体功能和心理健康相关?
Clin Orthop Relat Res. 2023 May 1;481(5):912-921. doi: 10.1097/CORR.0000000000002446. Epub 2022 Oct 6.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Oesophageal cancer-specific mortality risk and public health insurance: Prospective cohort study from China.食管癌特异性死亡风险与公共医疗保险:来自中国的前瞻性队列研究
World J Gastrointest Oncol. 2025 Apr 15;17(4):103629. doi: 10.4251/wjgo.v17.i4.103629.
2
Burden of esophageal cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.2019 年全球 204 个国家和地区食管癌发病和死亡负担及其归因危险因素分析。
Front Public Health. 2022 Sep 6;10:952087. doi: 10.3389/fpubh.2022.952087. eCollection 2022.
3
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Barrett 食管的诊断和管理:ACG 指南更新。
Am J Gastroenterol. 2022 Apr 1;117(4):559-587. doi: 10.14309/ajg.0000000000001680.
4
Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.饮食模式与症状严重程度与中国食管鳞癌及其组织学前体病变的风险:一项多中心横断面潜在类别分析。
BMC Cancer. 2022 Jan 21;22(1):95. doi: 10.1186/s12885-022-09206-y.
5
Mutant clones in normal epithelium outcompete and eliminate emerging tumours.正常上皮中的突变克隆会与新出现的肿瘤竞争并消除它们。
Nature. 2021 Oct;598(7881):510-514. doi: 10.1038/s41586-021-03965-7. Epub 2021 Oct 13.
6
Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma.食管腺癌患者总生存期和癌症特异性生存期的预测模型
J Oncol. 2021 Sep 14;2021:4138575. doi: 10.1155/2021/4138575. eCollection 2021.
7
Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.内镜检查后食管腺癌的幅度和时间趋势分析:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e31-e50. doi: 10.1016/j.cgh.2021.04.032. Epub 2021 Apr 23.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
10
Genomic copy number predicts esophageal cancer years before transformation.基因组拷贝数可在食管癌转化前数年预测。
Nat Med. 2020 Nov;26(11):1726-1732. doi: 10.1038/s41591-020-1033-y. Epub 2020 Sep 7.

保险覆盖范围与患者治疗结果:了解食管癌治疗的变化

Insurance coverage and patient outcomes: Understanding changes in esophageal cancer treatment.

作者信息

Mukundan Arvind, Nagisetti Yaswanth, Karmakar Riya, Wang Hsiang Chen

机构信息

Department of Chemistry, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.

Department of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan.

出版信息

World J Gastrointest Oncol. 2025 Jul 15;17(7):107154. doi: 10.4251/wjgo.v17.i7.107154.

DOI:10.4251/wjgo.v17.i7.107154
PMID:40697235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12278259/
Abstract

The article by Wu highlights the growing incidence of esophageal tumor patients, particularly in China, where the high frequency and death rate are significant problems. The article also examined the impact of health insurance on treatment availability and patient outcomes, demonstrating that the type of insurance can affect the financial burden on patients. This study investigates the effects of different types of health care coverage, namely Urban Employee Basic Medical Insurance Urban-Rural Resident Basic Medical Insurance, and the personal spending ratio on treatment decisions and survival outcomes. The database used is derived from esophageal tumor patient continuation from Chongqing University Hospital in China. A total of 2543 patients were included in the study, allowing for the formation of research cohorts. Patient information included demographic characteristics. The study followed various processes to maintain consistency, including data sources, inclusion and exclusion criteria, follow-up duration, health insurance, and statistical analysis. The average age at diagnosis ranged from 57-74 years, and predominantly included men, married people, and those of Han ethnic background, comprising 2088 and 2519 individuals, respectively. Upon controlling for age, sex, relationship status, country of origin, pathological evaluation, tumor stage, and biochemical indicators, individuals who had Urban Employee Basic Medical Insurance exhibited a higher propensity to opt for radiotherapy, chemotherapy, immunotherapy, and targeted therapy compared to those covered by the Urban-Rural Resident Basic Medical Insurance. During the follow-up phase of the study, a total of 1438 deaths were documented, with 1106 ascribed to esophageal cancer. Additionally, individuals with Urban-Rural Resident Basic Medical Insurance had a significantly elevated risk of esophageal cancer, particularly mortality, compared to those without Urban-Rural Resident Basic Medical Insurance.

摘要

吴的文章强调了食管癌患者发病率的不断上升,尤其是在中国,其高发病率和死亡率是重大问题。该文章还研究了医疗保险对治疗可及性和患者预后的影响,表明保险类型会影响患者的经济负担。本研究调查了不同类型的医疗保障,即城镇职工基本医疗保险、城乡居民基本医疗保险,以及个人支出比例对治疗决策和生存结局的影响。所使用的数据库来自中国重庆大学医院的食管癌患者延续数据。共有2543名患者纳入研究,从而形成了研究队列。患者信息包括人口统计学特征。该研究遵循了各种流程以保持一致性,包括数据来源、纳入和排除标准、随访时长、医疗保险以及统计分析。诊断时的平均年龄在57至74岁之间,主要包括男性、已婚人士以及汉族背景的人,分别有2088人和2519人。在控制了年龄、性别、婚姻状况、籍贯、病理评估、肿瘤分期和生化指标后,与参加城乡居民基本医疗保险的患者相比,参加城镇职工基本医疗保险的患者选择放疗、化疗、免疫治疗和靶向治疗的倾向更高。在研究的随访阶段,共记录了1438例死亡,其中1106例归因于食管癌。此外,与未参加城乡居民基本医疗保险的人相比,参加城乡居民基本医疗保险的人患食管癌的风险显著升高,尤其是死亡风险。